In: Economics
Access exclusive markets data when you subscribe to the FT
Our extensive director dealings data, financial analysis, and
forecasts are now only available to FT.com subscribers. To benefit
from this content, plus our exclusive data archive, subscribe to
the FT today. Subscribers benefit from access to:
Director Dealings
Take a deeper look into a company's insider transactions by viewing
director purchases and sales by individual directors.
5-year financials
The interactive charting tool provides extensive upper and lower
indicators, news and fundamental overlays, and comparison
features.
Sectors and Industries Content
Track sectors and industries performance, see top performing
companies, and find news relevant to you.
A Comprehensive Research Platform
Access bonds data, league tables and trends, world markets, macro
maps, economic calendar events, and data archives
Aceto Corporation (Aceto) is engaged in the marketing, sales and
distribution of finished dosage form generic pharmaceuticals,
nutraceutical products, pharmaceutical active ingredients and
intermediates, specialty performance chemicals inclusive of
agricultural intermediates and agricultural protection products.
The Company's business is organized along product lines into three
segments: Human Health, Pharmaceutical Ingredients and Performance
Chemicals. As of June 30, 2016, it distributed over 1,100 chemical
compounds used primarily as finished products or raw materials in
the agricultural, coatings and industrial chemical industries. The
Human Health segment includes finished dosage form generic drugs
and nutraceutical products. As of June 30, 2016, the Pharmaceutical
Ingredients segment had two product groups: Active Pharmaceutical
Ingredients and Pharmaceutical Intermediates. The Performance
Chemicals segment includes specialty chemicals and agricultural
protection products.
REVENUE IN USD (TTM)
682.93m
NET INCOME IN USD
-415.61m
INCORPORATED
1947
EMPLOYEES
315.00